After first introducing the M4 chip in May 2024, Apple is ready to move on to the newly announced M5. And, as customers have been led to expect when Apple moves one of its offerings from one number to ...

Diego is a writer and editor with over six years of experience covering games. He's mainly focused on guides, but he's done reviews, features, news, and everything in between. A fan of all genres, you ...

A new study uncovers how GIPR signaling in brain cells helps GLP-1 weight-loss drugs bypass the blood-brain barrier and amplify their appetite-suppressing effects, offering a mechanistic explanation ...

Amid a surge in research targeting cognitive disorders, the pharmaceutical industry is witnessing a wave of pivotal trial results that could reshape schizophrenia treatment paradigms. As biotech firms ...

The M1 Ultra Mac Studio is three years old, and for the "time is money" crowd, it might be time to update. Here's how the M1 Ultra Mac Studio compares to the M4 Max Mac Studio in 2025. It's about the ...

WATERTOWN, Mass., July 09, 2025 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (NMRA), a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of seven brain disease ...

Neumora Therapeutics, Inc. has announced the initiation of a Phase 1 study for NMRA-861, a potent and selective positive allosteric modulator of the M4 muscarinic receptor, aimed at treating ...

In this phase 3, open-label, randomized trial, we enrolled patients with ER-positive, human epidermal growth factor receptor 2 (HER2)–negative advanced breast cancer who had received one previous line ...

Mehrdad (He/Him) is a writer at GameRant. He started writing about video games when he was a high-school student. He loves playing competitive FPS games such as Rainbow Six Siege. In between, you can ...

SAN DIEGO, April 30, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the initiation of a Phase 3 registrational program to evaluate the efficacy, safety and ...